Regulatory

Articles

March 30, 2022

FDA Approves CartiHeal’s Agili-C Implant

FDA Approves CartiHeal’s Agili-C Implant
Approval is based on results of a clinical study that demonstrated superiority of Agili-C to debridement and microfracture in the knee joint.
February 16, 2022

Bonalive Granules Gain Breakthrough Device Designation

Bonalive Granules Gain Breakthrough Device Designation
Proposed indications include filling of bony voids and gaps, and protecting against microbial colonization while granules resorb and are replaced with bone.